Abstract:Poly(ADP-ribosyl) ation is a reversible post-translational protein modification implicated in the regulation of a number of biological functions. Whereas an 18 member superfamily of poly(ADP-ribose) polymerase (PARP) enzymes synthesize poly(ADP-ribose) (PAR), a single protein, PAR glycohydrolase (PARG) is responsible for the catabolism of the polymer. PARP-1 accounts for more than 90% of the poly(ADP-ribosyl)ating capacity of the cells. PARP-1 activated by DNA breaks cleaves NAD(+) into nicotinamide and ADP-ribose and uses the latter to synthesize long branching PAR polymers covalently attached to acceptor proteins including histones, DNA repair enzymes, transcription factors and PARP-1. Whereas activation of PARP-1 by mild genotoxic stimuli may facilitate DNA repair and cell survival, irreparable DNA damage triggers apoptotic or necrotic cell death. In apoptosis, early PARP activation may assist the apoptotic cascade [e.g. by stabilizing p53, by mediating the translocation of apoptosis inducing factor (AIF) from the mitochondria to the nucleus or by inhibiting early activation of DNases]. In most severe oxidative stress situations, excessive DNA damage causes over activation of PARP-1, which incapacitates the apoptotic machinery and switches the mode of cell death from apoptosis to necrosis. Besides serving as a cytotoxic mediator, PARP-1 is also involved in transcriptional regulation, most notably in the NF kappaB and AP-1 driven expression of inflammatory mediators. Pharmacological inhibition or genetic ablation of PARP-1 provided remarkable protection from tissue injury in various oxidative stress-related disease models ranging from stroke, diabetes, diabetic endothelial dysfunction, myocardial ischemia-reperfusion, shock, Parkinson's disease, arthritis, colitis to dermatitis and uveitis. These beneficial effects are attributed to inhibition of the PARP-1 mediated suicidal pathway and to reduced expression of inflammatory cytokines and other mediators (e.g. inducible nitric oxide synthase).

SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress

Human PARP1 Substrates and Regulators of Its Catalytic Activity: an Updated Overview.

Kinetics of Poly(adp-Ribosyl)ation, but Not PARP1 Itself, Determines the Cell Fate in Response to DNA Damage in Vitro and in Vivo.

Regulation of ADP-ribosyltransferase activity by ART domain dimerization in PARP15

Progress in the function and regulation of ADP-Ribosylation.

Covalent PARylation of DNA base excision repair proteins regulates DNA demethylation

Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1)

Mono-methylated histones control PARP-1 in chromatin and transcription

TARG1 protects against toxic DNA ADP-ribosylation

The expanding universe of PARP1-mediated molecular and therapeutic mechanisms

Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies

Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm

ADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent methylation of Ctcf target sites

Temporal regulation of acetylation status determines PARP1 role in DNA damage response and metabolic homeostasis

PARP7 mono-ADP-ribosylates the agonist conformation of the androgen receptor in the nucleus

The dePARylase NUDT16 promotes radiation resistance of cancer cells by blocking SETD3 for degradation via reversing its ADP-ribosylation

Regulation of PARP1/2 and the tankyrases: emerging parallels

Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions

Identification and Functional Characterizations of N-Terminal α-N-Methylation and Phosphorylation of Serine 461 in Human Poly(ADP-ribose) Polymerase 3.

Assessment of Intracellular Auto-Modification Levels of ARTD10 Using Mono-ADP-Ribose-Specific Macrodomains 2 and 3 of Murine Artd8.